Skip to Main Content

Paper Details

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression.
Oncoimmunology
0
2023
CTLA4, IL12, OC, PD1, T cells, VEGF, advanced ovarian cancer, anti-PD1, effector T cells, immunocompetent ID8-, mice, murine, myeloid cell, myeloid cells, ovarian cancer, suppressive immune cells populations, tumor, tumors
Author NameAffiliation
Vladimir MakarovCenter for Immunotherapy & Precision Immuno-Oncology (CITI), Lerner Research Institute, Cleveland Clinic
Vladimir MakarovCenter for Immunotherapy & Precision Immuno-Oncology (CITI), Lerner Research Institute, Cleveland Clinic
  • 1 - 2

Datasets

Release 1.2